Treace Medical Concepts Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	12.98	19.47	105.83	18.08	12.14
Short-Term Investments	110.22	61.78	0	0	0
Cash & Cash Equivalents	123.2	81.25	105.83	18.08	12.14
Cash Growth	51.62%	-23.23%	485.39%	48.93%	-
Receivables	38.06	29.2	18.57	14.49	10.41
Inventory	29.25	19.33	10.56	7.82	5.56
Other Current Assets	7.85	3.62	3.01	0.59	0.46
Total Current Assets	198.36	133.4	137.97	40.98	28.57
Property, Plant & Equipment	31.56	25.48	2.85	0.83	1.15
Goodwill and Intangibles	21.84	0	0	0	0
Other Long-Term Assets	0.15	0.15	0	0	0
Total Long-Term Assets	53.55	25.62	2.85	0.83	1.15
Total Assets	251.91	159.02	140.82	41.81	29.72
Accounts Payable	11.84	8.67	4.06	2.27	0.93
Current Debt	0	0	0	1.79	0
Other Current Liabilities	33.2	21.58	14.15	7.54	6.4
Total Current Liabilities	45.03	30.25	18.21	11.6	7.33
Long-Term Debt	68.9	68.25	29.37	29.19	19.22
Other Long-Term Liabilities	0.04	0	0.17	0.25	0
Total Long-Term Liabilities	68.94	68.25	29.54	29.43	19.22
Total Liabilities	113.97	98.5	47.75	41.03	26.56
Total Debt	68.9	68.25	29.37	30.98	19.22
Debt Growth	0.95%	132.42%	-5.20%	61.15%	-
Retained Earnings	-134.25	-84.72	-41.91	-21.35	-17.69
Comprehensive Income	0.16	-0.03	0	0	0
Shareholders' Equity	137.94	60.53	93.07	0.78	3.16
Net Cash / Debt	54.3	13	76.47	-12.9	-7.08
Net Cash / Debt Growth	317.62%	-83.00%	-	-	-
Net Cash Per Share	0.89	0.24	1.58	-0.35	-0.19
Working Capital	153.33	103.16	119.76	29.38	21.24
Book Value Per Share	2.27	1.09	1.92	0.02	0.09

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).